دورية أكاديمية
أعرض في EDS

Population ageing and healthcare expenditure projections: new evidence from a time to death approach.

التفاصيل البيبلوغرافية
العنوان: Population ageing and healthcare expenditure projections: new evidence from a time to death approach.
المؤلفون: Geue C; Health Economics and Health Technology Assessment, Institute of Health and Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow, G12 8RZ, UK, Claudia.Geue@glasgow.ac.uk., Briggs A, Lewsey J, Lorgelly P
المصدر: The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2014 Nov; Vol. 15 (8), pp. 885-96. Date of Electronic Publication: 2013 Nov 29.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134867 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-7601 (Electronic) Linking ISSN: 16187598 NLM ISO Abbreviation: Eur J Health Econ Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Berlin : Springer-Verlag, c2001-
مواضيع طبية MeSH: Health Expenditures/*statistics & numerical data, Age Factors ; Aged ; Aged, 80 and over ; Delivery of Health Care/economics ; Delivery of Health Care/statistics & numerical data ; Female ; Forecasting ; Health Expenditures/trends ; Humans ; Male ; Middle Aged ; Models, Econometric ; Mortality/trends ; Scotland/epidemiology ; Survival Analysis ; Time Factors
مستخلص: Background: Health care expenditure (HCE) is not distributed evenly over a person's life course. How much is spent on the elderly is important as they are a population group that is increasing in size. However other factors, such as death-related costs that are known to be high, need be considered as well in any expenditure projections and budget planning decisions.
Objective: This article analyses, for the first time in Scotland, how expenditure projections for acute inpatient care are influenced when applying two different analytical approaches: (1) accounting for healthcare (HC) spending at the end of life and (2) accounting for demographic changes only. The association between socioeconomic status and HC utilisation and costs at the end of life is also estimated.
Methods: A representative, longitudinal data set is used. Survival analysis is employed to allow inclusion of surviving sample members. Cost estimates are derived from a two-part regression model. Future population estimates were obtained for both methods and multiplied separately by cost estimates.
Results: Time to death (TTD), age at death and the interaction between these two have a significant effect on HC costs. As individuals approach death, those living in more deprived areas are less likely to be hospitalised than those individuals living in the more affluent areas, although this does not translate into incurring statistically significant higher costs. Projected HCE for acute inpatient care for the year 2028 was approximately 7% higher under the demographic approach as compared to a TTD approach.
Conclusion: The analysis showed that if death is postponed into older ages, HCE (and HC budgets) would not increase to the same extent if these factors were ignored. Such factors would be ignored if the population that is in their last year(s) of life were not taken into consideration when obtaining cost estimates.
References: Health Econ Policy Law. 2008 Apr;3(Pt 2):165-95. (PMID: 18634626)
Soc Sci Med. 2011 Jan;72(2):173-84. (PMID: 21131119)
Health Econ. 2004 Apr;13(4):303-14. (PMID: 15067669)
Milbank Q. 2007 Jun;85(2):213-57. (PMID: 17517114)
J Health Serv Res Policy. 2012 Oct;17(4):197-205. (PMID: 23038709)
BMJ. 1997 Mar 15;314(7083):820-5. (PMID: 9081009)
Eur J Health Econ. 2015 Jan;16(1):95-112. (PMID: 24585039)
Health Econ. 2004 Apr;13(4):315-27. (PMID: 15067670)
Age Ageing. 2000 May;29(3):249-53. (PMID: 10855908)
J Health Econ. 2012 Dec;31(6):876-87. (PMID: 23000700)
Health Econ. 1999 Sep;8(6):485-96. (PMID: 10544314)
Health Policy. 2008 Mar;85(3):380-90. (PMID: 17913279)
Age Ageing. 2004 Nov;33(6):556-61. (PMID: 15308460)
Health Econ. 2012 Oct;21(10):1201-16. (PMID: 21905152)
Health Policy. 2002 Nov;62(2):161-72. (PMID: 12354410)
Lancet. 2001 Oct 13;358(9289):1213-7. (PMID: 11675057)
معلومات مُعتمدة: United Kingdom Chief Scientist Office; United Kingdom Medical Research Council
تواريخ الأحداث: Date Created: 20131203 Date Completed: 20150622 Latest Revision: 20220408
رمز التحديث: 20240513
DOI: 10.1007/s10198-013-0543-7
PMID: 24292437
قاعدة البيانات: MEDLINE
الوصف
تدمد:1618-7601
DOI:10.1007/s10198-013-0543-7